In Silico and In Vitro Potential of FDA-Approved Drugs for Antimalarial Drug Repurposing against <i>Plasmodium</i> Serine Hydroxymethyltransferases-Reference-Cited by-同舟云学术

In Silico and In Vitro Potential of FDA-Approved Drugs for Antimalarial Drug Repurposing against Plasmodium Serine Hydroxymethyltransferases

Published:2023-09-18 Issue:39 Volume:8 Page:35580-35591
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Mee-udorn Pitchayathida¹^ORCID,Phiwkaow Kochakorn²,Tinikul Ruchanok³,Sanachai Kamonpan⁴^ORCID,Maenpuen Somchart²,Rungrotmongkol Thanyada¹⁵^ORCID

Affiliation:

1. Program in Bioinformatics and Computational Biology, Graduate School, Chulalongkorn University, Bangkok 10330, Thailand

2. Department of Biochemistry, Faculty of Science, Burapha University, Chonburi 20131, Thailand

3. Department of Biochemistry and Center for Excellence in Protein and Enzyme Technology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand

4. Department of Biochemistry, Faculty of Science, Khon Kaen University, Khon Kaen 40002, Thailand

5. Center of Excellence in Biocatalyst and Sustainable Biotechnology, Department of Biochemistry, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand

Funder

Burapha University

National Research Council of Thailand

Faculty of Science, Mahidol University

Ministry of Higher Education, Science, Research and Innovation, Thailand

Chulalongkorn University

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.3c01309